NCT03536143: A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients
- State
- Completed
- Phase
- Phase 1 and Phase 2
- People
- 12 taking part
- Started
- 6 May 2018
- Primary completion
- 1 Nov 2019
- Arms
- Topical beremagene geperpavec
- Results
- Posted on the registry
- 6 May 2018: Trial started
- 24 May 2018: Trial registered
- 1 Nov 2019: Trial completed
- 31 Jan 2023: Trial results posted